287 related articles for article (PubMed ID: 26471505)
1. Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.
Pavlides M; Banerjee R; Sellwood J; Kelly CJ; Robson MD; Booth JC; Collier J; Neubauer S; Barnes E
J Hepatol; 2016 Feb; 64(2):308-315. PubMed ID: 26471505
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.
Pavlides M; Banerjee R; Tunnicliffe EM; Kelly C; Collier J; Wang LM; Fleming KA; Cobbold JF; Robson MD; Neubauer S; Barnes E
Liver Int; 2017 Jul; 37(7):1065-1073. PubMed ID: 27778429
[TBL] [Abstract][Full Text] [Related]
3. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.
Imajo K; Tetlow L; Dennis A; Shumbayawonda E; Mouchti S; Kendall TJ; Fryer E; Yamanaka S; Honda Y; Kessoku T; Ogawa Y; Yoneda M; Saito S; Kelly C; Kelly MD; Banerjee R; Nakajima A
World J Gastroenterol; 2021 Feb; 27(7):609-623. PubMed ID: 33642832
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging metrics and the predictability of adverse outcomes in on-treatment Asian chronic hepatitis B.
Hui RW; Chiu KW; Mak LY; Chang HC; Cheung KS; Fung J; Yuen MF; Seto WK
J Gastroenterol Hepatol; 2022 Jun; 37(6):1139-1147. PubMed ID: 35368120
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease.
Kim JW; Lee YS; Park YS; Kim BH; Lee SY; Yeon JE; Lee CH
Sci Rep; 2020 Feb; 10(1):2671. PubMed ID: 32060386
[TBL] [Abstract][Full Text] [Related]
6. The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study.
Idilman IS; Celik A; Savas B; Idilman R; Karcaaltincaba M
Clin Radiol; 2021 Sep; 76(9):709.e13-709.e18. PubMed ID: 34266657
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MR assessment of liver fat, iron, and fibrosis: a concise overview of the liver "Triple Screen".
Low G; Ferguson C; Locas S; Tu W; Manolea F; Sam M; Wilson MP
Abdom Radiol (NY); 2023 Jun; 48(6):2060-2073. PubMed ID: 37041393
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study.
McDonald N; Eddowes PJ; Hodson J; Semple SIK; Davies NP; Kelly CJ; Kin S; Phillips M; Herlihy AH; Kendall TJ; Brown RM; Neil DAH; Hübscher SG; Hirschfield GM; Fallowfield JA
Sci Rep; 2018 Jun; 8(1):9189. PubMed ID: 29907829
[TBL] [Abstract][Full Text] [Related]
9. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
[TBL] [Abstract][Full Text] [Related]
10. Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease.
Eddowes PJ; McDonald N; Davies N; Semple SIK; Kendall TJ; Hodson J; Newsome PN; Flintham RB; Wesolowski R; Blake L; Duarte RV; Kelly CJ; Herlihy AH; Kelly MD; Olliff SP; Hübscher SG; Fallowfield JA; Hirschfield GM
Aliment Pharmacol Ther; 2018 Mar; 47(5):631-644. PubMed ID: 29271504
[TBL] [Abstract][Full Text] [Related]
11. Radiologic evaluation of nonalcoholic fatty liver disease.
Lee SS; Park SH
World J Gastroenterol; 2014 Jun; 20(23):7392-402. PubMed ID: 24966609
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease.
Banerjee R; Pavlides M; Tunnicliffe EM; Piechnik SK; Sarania N; Philips R; Collier JD; Booth JC; Schneider JE; Wang LM; Delaney DW; Fleming KA; Robson MD; Barnes E; Neubauer S
J Hepatol; 2014 Jan; 60(1):69-77. PubMed ID: 24036007
[TBL] [Abstract][Full Text] [Related]
13. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
Brouha SS; Nguyen P; Bettencourt R; Sirlin CB; Loomba R
Eur Radiol; 2018 Apr; 28(4):1345-1355. PubMed ID: 29058029
[TBL] [Abstract][Full Text] [Related]
14. Quantification of steatosis in alcoholic and nonalcoholic fatty liver disease: Evaluation of four MR techniques versus biopsy.
Boudinaud C; Abergel A; Joubert-Zakeyh J; Fontarensky M; Pereira B; Chauveau B; Garcier JM; Chabrot P; Boyer L; Magnin B
Eur J Radiol; 2019 Sep; 118():169-174. PubMed ID: 31439237
[TBL] [Abstract][Full Text] [Related]
15. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
[TBL] [Abstract][Full Text] [Related]
16. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease.
Imajo K; Honda Y; Yoneda M; Saito S; Nakajima A
J Med Ultrason (2001); 2020 Oct; 47(4):535-548. PubMed ID: 33108553
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
Jayakumar S; Middleton MS; Lawitz EJ; Mantry PS; Caldwell SH; Arnold H; Mae Diehl A; Ghalib R; Elkhashab M; Abdelmalek MF; Kowdley KV; Stephen Djedjos C; Xu R; Han L; Mani Subramanian G; Myers RP; Goodman ZD; Afdhal NH; Charlton MR; Sirlin CB; Loomba R
J Hepatol; 2019 Jan; 70(1):133-141. PubMed ID: 30291868
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease.
Schaapman JJ; Tushuizen ME; Coenraad MJ; Lamb HJ
J Magn Reson Imaging; 2021 Jun; 53(6):1623-1631. PubMed ID: 32822095
[TBL] [Abstract][Full Text] [Related]
20. Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis.
Bril F; Barb D; Lomonaco R; Lai J; Cusi K
J Hepatol; 2020 Mar; 72(3):401-410. PubMed ID: 31589891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
